After hearing Dr. Wachman’s overview of current best practice recommendations for the inpatient care of opioid-exposed infants with neonatal abstinence syndrome (NAS), including the optimization of non-pharmacologic care, parental engagement, and new pharmacologic treatment strategies, participants will understand the use of non-pharmacologic treatment strategies for NAS including rooming-in and breastfeeding and the use of novel NAS assessment methods and pharmacologic treatment strategies that compliment non-pharmacologic care.
Funding for this initiative was made possible (in part) by grant no. 1H79T1080816-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services: nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
The Maine Medical Education Trust designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
Friday, November 16, 2018
About the Presenter
Dr. Elisha Wachman, MD. Dr. Elisha Wachman received her MD from the Boston University School of Medicine before pursuing her pediatric residency at Boston Medical Center (BMC) and Children’s Hospital Boston. She then completed her neonatology fellowship at the Floating Hospital for Children at Tufts Medical Center. She is currently an attending neonatologist at BMC and a leader in neonatal abstinence syndrome (NAS) quality improvement and research at BMC, throughout Massachusetts, and nationally. Her research primarily focuses on examining genetic and epigenetic predictors of NAS outcomes. Her other primary research interests include breastfeeding in the setting of maternal substance use disorders, use of non-pharmacologic care to improve NAS outcomes, and development of the new Eat, Sleep, Console NAS assessment method. She is currently of the leaders of the Massachusetts neoQIC NAS Quality Improvement Collaborative, and the Principal Investigator of a MA Health Policy Commission NAS Investment Grant.